Brief: Investor Group Recommends Stockholders Vote The White Proxy Card For Boardroom Change At Pasithea Therapeutics
07/12/2022 21:26
Dec 7 (Reuters) -
* INVESTOR GROUP RECOMMENDS STOCKHOLDERS VOTE THE WHITE
PROXY CARD
FOR BOARDROOM CHANGE AT PASITHEA THERAPEUTICS
Source text for Eikon: ID:nBw1Hd4kDa
Further company coverage: KTTA.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Pasithea Therapeutics
See all newsPasithea Therapeutics Corp reports results for the quarter ended June 30 - Earnings Summary
Pasithea Therapeutics Corp expected to post a loss of 16 cents a share - Earnings Preview
Brief: Pasithea Therapeutics Announces Positive Interim Phase 1 Advanced Cancer Study Data
Brief: Pasithea Therapeutics Announces Closing Of $60 Million Public Offering Of Common Stock
Pasithea Therapeutics jumps after $60 million public offering announcement